MS in the Media - 27 September 2019
21 - 27 September 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Should vitamin D supplements be recommended for MS?
Whether people with MS should take vitamin D supplements or not was the topic of a debate at the recent ECTRIMS conference. The Yes argument centred on reduced risk of developing MS in people with higher vitamin D levels. Use in people who have MS is harder to judge. The No argument said that low vitamin D may be caused by MS rather than the other way round and that UV light exposure may be more important. Both sides agree there is not enough good research yet to be sure.
Source: MS News Today
MS Trust link: Vitamin D
More MS genes discovered
The latest report by the International MS Genetics Consortium has identified 233 genes variations that add to the risk of developing MS. The affected genes are in areas associated with immune function. There is also a genetic variant on chromosome X, which may be linked to why women are more likely to get MS than men
Source: National MS Society (USA)
MS Trust link: Causes of MS
Beta interferon and pregnancy
The EMA (European Medicines Agency) is considering a recommendation to allow the use of interferon beta 1a (Avonex, Plegridy and Rebif) during the early stages of pregnancy and breastfeeding, Data showed no increase in danger to the baby of women taking the drug at time of conception or in the first trimester.
Source: Biogen press release
Source: Merck press release
MS Trust link: New guidelines for pregnancy in multiple sclerosis
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
